Matt Gline

Roivant’s Matt Gline on the hub-and-spoke biotech model and lessons learned from Axovant
Biopharma Dive
Mon, 01/23/23 - 09:45 pm
Roivant Sciences
IBD
Pfizer
Matt Gline
hub-and-spoke